Cargando…
Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience
PURPOSE: This multicenter, randomized, crossover study compared preference, ease of use, acceptability, satisfaction, and safety of repeated subcutaneous (SC) self-administrations with prefilled pens and prefilled syringes delivering methotrexate (MTX), in patients with rheumatoid arthritis (RA). PA...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130714/ https://www.ncbi.nlm.nih.gov/pubmed/25125973 http://dx.doi.org/10.2147/PPA.S64111 |
_version_ | 1782330372926734336 |
---|---|
author | Demary, Winfried Schwenke, Holger Rockwitz, Karin Kästner, Peter Liebhaber, Anke Schoo, Ulrich Hübner, Georg Pichlmeier, Uwe Guimbal-Schmolck, Cécile Müller-Ladner, Ulf |
author_facet | Demary, Winfried Schwenke, Holger Rockwitz, Karin Kästner, Peter Liebhaber, Anke Schoo, Ulrich Hübner, Georg Pichlmeier, Uwe Guimbal-Schmolck, Cécile Müller-Ladner, Ulf |
author_sort | Demary, Winfried |
collection | PubMed |
description | PURPOSE: This multicenter, randomized, crossover study compared preference, ease of use, acceptability, satisfaction, and safety of repeated subcutaneous (SC) self-administrations with prefilled pens and prefilled syringes delivering methotrexate (MTX), in patients with rheumatoid arthritis (RA). PATIENTS AND METHODS: The study (ClinicalTrials.gov number NCT01793259) enrolled 120 patients requiring initiation or intensification of MTX therapy for RA. Patients were randomized to receive the test drug, a prefilled pen (Metex(®) PEN/Metoject(®) PEN), or the reference drug, a prefilled syringe (Metex(®)/Metoject(®)), at doses of 15, 17.5, or 20 mg MTX SC once a week for 3 weeks. This was followed by receipt of the reference drug (prefilled syringe) or the test drug (prefilled pen) in a crossover design, with each patient serving as his/her own control. Questionnaires regarding patient preference, the Self-Injection Assessment Questionnaire (SIAQ), and diaries regarding local tolerability were used to document outcomes. RESULTS: Overall patient preference for the MTX prefilled pen was 75% (P<0.0001). In a six-item questionnaire, 73% to 76% of the patients preferred the prefilled pen in relation to use, acceptability, and satisfaction, and 67% of the patients confirmed that it did not take much effort to overcome SC self-injection with the pen. The SIAQ showed no clinical differences, in any domain scores, between both devices. Overall patient attitude towards self-injection at baseline was positive, as was patient experience with both devices during the study. As well, 92% of physicians and study nurses indicated that they would recommend the MTX prefilled pen to patients for future MTX treatment. The formulations were generally well tolerated. CONCLUSION: SC self-injection of MTX with a prefilled pen was generally preferred, by patients with RA, over a prefilled syringe with regard to use, acceptability, and satisfaction. This is supported by the strong appreciation of their attending study nurses and physicians, for its convenience. |
format | Online Article Text |
id | pubmed-4130714 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-41307142014-08-14 Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience Demary, Winfried Schwenke, Holger Rockwitz, Karin Kästner, Peter Liebhaber, Anke Schoo, Ulrich Hübner, Georg Pichlmeier, Uwe Guimbal-Schmolck, Cécile Müller-Ladner, Ulf Patient Prefer Adherence Original Research PURPOSE: This multicenter, randomized, crossover study compared preference, ease of use, acceptability, satisfaction, and safety of repeated subcutaneous (SC) self-administrations with prefilled pens and prefilled syringes delivering methotrexate (MTX), in patients with rheumatoid arthritis (RA). PATIENTS AND METHODS: The study (ClinicalTrials.gov number NCT01793259) enrolled 120 patients requiring initiation or intensification of MTX therapy for RA. Patients were randomized to receive the test drug, a prefilled pen (Metex(®) PEN/Metoject(®) PEN), or the reference drug, a prefilled syringe (Metex(®)/Metoject(®)), at doses of 15, 17.5, or 20 mg MTX SC once a week for 3 weeks. This was followed by receipt of the reference drug (prefilled syringe) or the test drug (prefilled pen) in a crossover design, with each patient serving as his/her own control. Questionnaires regarding patient preference, the Self-Injection Assessment Questionnaire (SIAQ), and diaries regarding local tolerability were used to document outcomes. RESULTS: Overall patient preference for the MTX prefilled pen was 75% (P<0.0001). In a six-item questionnaire, 73% to 76% of the patients preferred the prefilled pen in relation to use, acceptability, and satisfaction, and 67% of the patients confirmed that it did not take much effort to overcome SC self-injection with the pen. The SIAQ showed no clinical differences, in any domain scores, between both devices. Overall patient attitude towards self-injection at baseline was positive, as was patient experience with both devices during the study. As well, 92% of physicians and study nurses indicated that they would recommend the MTX prefilled pen to patients for future MTX treatment. The formulations were generally well tolerated. CONCLUSION: SC self-injection of MTX with a prefilled pen was generally preferred, by patients with RA, over a prefilled syringe with regard to use, acceptability, and satisfaction. This is supported by the strong appreciation of their attending study nurses and physicians, for its convenience. Dove Medical Press 2014-08-06 /pmc/articles/PMC4130714/ /pubmed/25125973 http://dx.doi.org/10.2147/PPA.S64111 Text en © 2014 Demary et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Demary, Winfried Schwenke, Holger Rockwitz, Karin Kästner, Peter Liebhaber, Anke Schoo, Ulrich Hübner, Georg Pichlmeier, Uwe Guimbal-Schmolck, Cécile Müller-Ladner, Ulf Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience |
title | Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience |
title_full | Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience |
title_fullStr | Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience |
title_full_unstemmed | Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience |
title_short | Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience |
title_sort | subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130714/ https://www.ncbi.nlm.nih.gov/pubmed/25125973 http://dx.doi.org/10.2147/PPA.S64111 |
work_keys_str_mv | AT demarywinfried subcutaneouslyadministeredmethotrexateforrheumatoidarthritisbyprefilledsyringesversusprefilledpenspatientpreferenceandcomparisonoftheselfinjectionexperience AT schwenkeholger subcutaneouslyadministeredmethotrexateforrheumatoidarthritisbyprefilledsyringesversusprefilledpenspatientpreferenceandcomparisonoftheselfinjectionexperience AT rockwitzkarin subcutaneouslyadministeredmethotrexateforrheumatoidarthritisbyprefilledsyringesversusprefilledpenspatientpreferenceandcomparisonoftheselfinjectionexperience AT kastnerpeter subcutaneouslyadministeredmethotrexateforrheumatoidarthritisbyprefilledsyringesversusprefilledpenspatientpreferenceandcomparisonoftheselfinjectionexperience AT liebhaberanke subcutaneouslyadministeredmethotrexateforrheumatoidarthritisbyprefilledsyringesversusprefilledpenspatientpreferenceandcomparisonoftheselfinjectionexperience AT schooulrich subcutaneouslyadministeredmethotrexateforrheumatoidarthritisbyprefilledsyringesversusprefilledpenspatientpreferenceandcomparisonoftheselfinjectionexperience AT hubnergeorg subcutaneouslyadministeredmethotrexateforrheumatoidarthritisbyprefilledsyringesversusprefilledpenspatientpreferenceandcomparisonoftheselfinjectionexperience AT pichlmeieruwe subcutaneouslyadministeredmethotrexateforrheumatoidarthritisbyprefilledsyringesversusprefilledpenspatientpreferenceandcomparisonoftheselfinjectionexperience AT guimbalschmolckcecile subcutaneouslyadministeredmethotrexateforrheumatoidarthritisbyprefilledsyringesversusprefilledpenspatientpreferenceandcomparisonoftheselfinjectionexperience AT mullerladnerulf subcutaneouslyadministeredmethotrexateforrheumatoidarthritisbyprefilledsyringesversusprefilledpenspatientpreferenceandcomparisonoftheselfinjectionexperience |